Lack of effect of central nervous system‐active doses of nabilone on capsaicin‐induced pain and hyperalgesia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1681.2012.05674.xPMID 22233155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers

  2010cited by this paper
• A peripherally restricted cannabinoid receptor agonist produces robust anti‐nociceptive effects in rodent models of inflammatory and neuropathic pain

  2010cited by this paper
• Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

  2010cited by this paper
• Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

  2009cited by this paper
• Biomarkers for the effects of cannabis and THC in healthy volunteers.

  2009cited by this paper
• Systematic review and meta-analysis of cannabis treatment for chronic pain.

  2009cited by this paper
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  2009cited by this paper
• Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

  2008cited by this paper
• Nabilone for the treatment of pain in fibromyalgia.

  2008cited by this paper
• Lack of Analgesia by Oral Standardized Cannabis Extract on Acute Inflammatory Pain and Hyperalgesia in Volunteers

  2008influential reference
• Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

  2007cited by this paper
• Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers

  2007influential reference
• Cannabis in painful HIV-associated sensory neuropathy

  2007cited by this paper
• Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

  2007cited by this paper
• Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double‐blind, placebo‐controlled clinical trial

  2007cited by this paper
• A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management

  2006cited by this paper
• Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.

  2006cited by this paper
• Effects of nabilone, a synthetic cannabinoid, on postoperative pain

  2006cited by this paper
• The endocannabinoid system: a drug discovery perspective.

  2005cited by this paper
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper
• Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.

  2005cited by this paper
• Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

  2005cited by this paper
• Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

  2004cited by this paper
• The analgesic effect of oral delta‐9‐tetrahydrocannabinol (THC), morphine, and a THC‐morphine combination in healthy subjects under experimental pain conditions

  2003cited by this paper
• Cannabinoids and pain

  2003cited by this paper
• Cannabinoid agonists attenuate capsaicin‐induced responses in human skin

  2003cited by this paper
• Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

  2003cited by this paper
• Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

  2003cited by this paper
• Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

  2001cited by this paper
• Characterization of secondary hyperalgesia produced by topical capsaicin jelly—a new experimental tool for pain research

  2001cited by this paper
• Universities and tobacco money

  2001cited by this paper
• Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

  2000cited by this paper
• The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction.

  1998influential reference
• Dose‐dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin

  1989cited by this paper
• Single‐Dose Study of Nabilone in Anxious Volunteers

  1981cited by this paper
• Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain

  1981cited by this paper
• Physiologic disposition of nabilone, a cannabinol derivative, in man

  1977cited by this paper
• The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine

  1975cited by this paper
• Clinical pharmacology of nabilone, a cannabinol derivative

  1975influential reference
• Reliability, validity, and clinical application of the visual analogue mood scale

  1973cited by this paper

• CB1R and GlyT2 interaction in spinal glycinergic circuits drives neuropathic mechanical pain.

  2026cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials

  2022influential citation
• Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

  2022cites this paper
• Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I).

  2021cites this paper
• A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids.

  2021cites this paper
• Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis

  2020cites this paper
• Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review.

  2019cites this paper
• A Budding Cannabis Cottage-Industry has set the stage for an Impending Public Health Crisis

  2018cites this paper
• The role of cannabinoids in pain control: the good, the bad, and the ugly.

  2018cites this paper
• Association of Cannabinoid Administration With Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis

  2018cites this paper
• Chapter 85 – The Synthetic Analog of Δ9-Tetrahydrocannabinol (THC): Nabilone. Pharmacology and Clinical Application

  2017cites this paper
• A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models.

  2016cites this paper
• Medical marijuana for cancer

  2015cites this paper
• Pain and the Thermally Injured Patient—A Review of Current Therapies

  2015cites this paper
• Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin‐induced pain and hyperalgesia

  2013cites this paper
• Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

  2013cites this paper
• Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal

  2013cites this paper
• Nabilone in inflammatory pain: to be or not to be

  2012cites this paper
• : Is it time to consign the term “ nonspecific low back pain ” to history ?

  year unknowncites this paper